Jesus Rodriguez-Munoz
Sabadell, CT 08202, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
SOGUG Multidisciplinary Expert Panel Consensus on Updated Diagnosis and Characterization of Prostate Cancer Patients.
Journal: Current oncology (Toronto, Ont.)
Published: November 21, 2025
CT-Based Quantification of Prostate Volume Change After LHRH-Agonist Androgen Deprivation: A Prospective, Three-Reader Study for Radiotherapy Planning.
Journal: Life (Basel, Switzerland)
Published: November 18, 2025
Integral Approach in the Follow-up of Prostate Cancer Patients: SOGUG Multidisciplinary Expert Panel Insights.
Journal: Clinical genitourinary cancer
Published: October 24, 2025
Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations.
Journal: Cancers
Published: July 16, 2025
Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With Apalutamide.
Journal: The Prostate
Published: June 03, 2025
Fracture risk assessment in patients with ileal urinary diversion after radical cystectomy: a comprehensive evaluation integrating bone mineral density, trabecular bone score, and FRAX®.
Journal: Archives of osteoporosis
Published: May 23, 2025
Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired-Matched Study.
Journal: Diagnostics (Basel, Switzerland)
Published: January 01, 2025
Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients.
Journal: Actas urologicas espanolas
Published: November 21, 2024
The Role of Digital Rectal Examination for Early Detection of Significant Prostate Cancer in the Era of Magnetic Resonance Imaging.
Journal: Life (Basel, Switzerland)
Published: September 05, 2024
Evaluating the Quality of Local Programs for Early Detection of Significant Prostate Cancer.
Journal: European urology open science
Published: June 04, 2024
PSMA PET/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 08, 2024
Last Updated: 09/26/2026